Congress Restores $33.5M Funding for CDC’s Asthma Control Program After Budget Omission
Event summary
- Congress restored $33.5M in funding for the CDC’s National Asthma Control Program (NACP) after it was omitted from the 2026 budget.
- The bipartisan effort ensures NACP’s continuation through September 2026.
- AAFA’s advocacy campaign included 2,200+ emails to Congress supporting the program.
- NACP reduces asthma mortality by 45% and delivers a $71 ROI from reduced healthcare costs.
- The program supports asthma initiatives in 29 states and four non-governmental organizations.
The big picture
The restoration of NACP funding highlights Congress’s recognition of the program’s cost-effectiveness and public health value. This bipartisan support contrasts with the initial budget omission, signaling potential volatility in federal funding for specialized health initiatives. The program’s $71 ROI underscores its efficiency, positioning it as a model for other public health interventions.
What we're watching
- Budget Uncertainty
- Whether Congress will expand NACP funding in the 2027 budget cycle, as AAFA has requested.
- Program Impact
- The pace at which NACP’s state-level initiatives demonstrate measurable improvements in asthma management.
- Advocacy Influence
- How AAFA’s grassroots efforts will shape future funding decisions for public health programs.